BioSpace News Archive

Select Medical Holdings Corporation, the parent of Select Medical Corporation (collectively, “Select Medical”), today announced that it has formed a component Patient Safety Organization (PSO) that has been federally listed by the Agency for Healthcare Research and Quality (AHRQ

Spectrum Dynamics, a global leader, developer, manufacturer and seller of specialized SPECT cardiac imaging equipment, filed a lawsuit today against GE for theft and misappropriation of Spectrum Dynamics’ trade secrets and intellectual property in the United States District Court for the Southern District of New York.

The Board of Directors for The Villages Health is pleased to announce the appointment of Bob Trinh as its new Chief Executive Officer.

The Board of Directors of PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (OTC: PDRX) today announced that it has declared a onetime dividend of $2.20 per share payable on December 12, 2018 to shareholders of record at the close of business November 30, 2018.

In its annual review of medical and scientific discoveries, the publication Reader’s Digest named DotLab as one of the “Amazing Medical Breakthroughs of 2018.” DotLab is recognized for its DotEndo product - the world’s first-ever, non-invasive test for endometriosis.

The forces leading to detachment and depersonalization among burned-out primary care physicians are similar to the factors responsible for populist movements—the perception of a rigged system favoring a managerial elite, according to a commentary in the December issue of The American Journal of Managed Care. ®

Maryland University of Integrative Health (MUIH) and Leadership Maryland announced today that Steven C. “Steve” Combs, Ph.D., President and CEO of MUIH, has completed the professional development program dedicated to building a better Maryland by harnessing the strength of its local business and community leaders

Orexo AB (publ.) is today hosting the Company’s Capital Markets Day for investors, analysts and media in Stockholm, Sweden.

Confo Therapeutics today announces the appointment of Frank Landolt as its Chief Counsel Legal & IP, effective from 1 January 2019.

Monoclonal antibody TY014 advanced from initiation to clinical development in seven months